1. Berberine associated to SGLT2i Dapagliflozin synergistically reduces cardiac cell apoptosis during exposure to Trastuzumab through reduction of AGEs and IL-6 and induction of pAMPK. (3rd October 2022) Authors: Maurea, N; Buccolo, S; Iovine, M; Maurea, C; Paccone, A; Quagliariello, V Journal: European heart journal Issue: Volume 43(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Sacubitril-valsartan activates pAMPK and reduces NLRP3, MyD88, cytokines/growth factors and DAMPs in doxorubicin-treated mice improving longitudinal strain and ejection fraction. (3rd October 2022) Authors: Maurea, N; Buccolo, S; Iovine, M; Paccone, A; Luciano, A; Barbieri, A; Palma, G; Maurea, C; Quagliariello, V Journal: European heart journal Issue: Volume 43(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Sacubitril-valsartan improves radial and longitudinal strain and ejection fraction in C57Bl/6 mice treated with doxorubicin through NLRP3 mediated pathways and reduction of cytokine storm. (4th February 2022) Authors: Quagliariello, V; Buccolo, S; Iovine, M; Maurea, C; Rea, D; Barbieri, A; Maurea, N Journal: European heart journal Issue: Volume 23(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗